Latest Breaking News On - Neurodegenerative disease program - Page 1 : comparemela.com

Targeting neurodegenerative diseases such as Alzheimer’s, Huntington’s and Parkinson’sIdentified two lead cannabinoid analog compounds for in vivo.

United kingdomBritish columbiaEric hsuUjendra kumarColin clancyInmed pharmaceuticalsCompany nasdaqAlliance grant fundingPharmaceuticals sciencesExchange commissionUniversity of british columbiaA neurodegenerative disease programInmed pharmaceuticals incPreclinical research developmentMed pharmaceuticalsSenior vice president